Sandoz Group Ltd Sponsored ADR (SDZNY) Price & Analysis

Compare

89 Followers

SDZNY Stock Chart & Stats

$74.31

$0.55(1.34%)

At close: Jan 08 4:00 PM EST

$74.31

$0.55(1.34%)

Day’s Range― - ―

52-Week Range$36.26 - $74.38

Previous CloseN/A

Volume11.52K

Average Volume (3M)1.03K

Market Cap

$32.72B

Enterprise Value$28.08B

Total Cash (Recent Filing)$1.39B

Total Debt (Recent Filing)$5.69B

Price to Earnings (P/E)139.6

Beta0.36

Next Earnings

Mar 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.98%

Share Statistics

EPS (TTM)0.88

Shares Outstanding440,000,000

10 Day Avg. Volume0

30 Day Avg. Volume1,031

Financial Highlights & Ratios

PEG Ratio-174.11

Price to Book (P/B)2.13

Price to Sales (P/S)1.68

P/FCF Ratio290.18

Enterprise Value/Market Cap0.86

Enterprise Value/Revenue3.12

Enterprise Value/Gross Profit6.65

Enterprise Value/Ebitda33.68

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Sandoz Group Ltd Sponsored ADR News

Sandoz initiated with a Neutral at Oddo BHF

Oddo BHF analyst Martial Descoutures initiated coverage of Sandoz (SDZNY) with a Neutral rating and CHF 57 price...

10d ago

Sandoz price target raised to CHF 60 from CHF 55 at Deutsche Bank

Deutsche Bank analyst Emmanuel Papadakis raised the firm’s price target on Sandoz (SDZNY) to CHF 60 from CHF...

1M ago

Sandoz price target raised to CHF 60 from CHF 55 at JPMorgan

JPMorgan raised the firm’s price target on Sandoz (SDZNY) to CHF 60 from CHF 55 and keeps an...

2M ago

Evotec to sell Just – Evotec Biologics EU, license technology to Sandoz

Evotec (EVO) announced the successful signing of the sale of the Just – Evotec Biologics Toulouse site to...

2M ago

EVO

Sandoz participates in a conference call with Jefferies

Conference call with management to be held on November 11 at 5:15 am hosted by Jefferies. Published first...

2M ago

Sandoz price target raised to CHF 49 from CHF 41 at Berenberg

Berenberg analyst Beatrice Fairbairn raised the firm’s price target on Sandoz (SDZNY) to CHF 49 from CHF 41...

2M ago

Sandoz price target raised to CHF 55 from CHF 46 at JPMorgan

JPMorgan raised the firm’s price target on Sandoz (SDZNY) to CHF 55 from CHF 46 and keeps an...

3M ago

Sandoz reaches agreement with Regeneron over patent litigation

Sandoz (SDZNY) announced that it has reached an agreement with Regeneron Pharmaceuticals (REGN), to resolve all patent disputes...

4M ago

REGN

Sandoz price target raised to CHF 55 from CHF 48 at Deutsche Bank

Deutsche Bank analyst Emmanuel Papadakis raised the firm’s price target on Sandoz (SDZNY) to CHF 55 from CHF...

4M ago

Sandoz price target raised to CHF 53 from CHF 44 at RBC Capital

RBC Capital analyst Alistair Campbell raised the firm’s price target on Sandoz (SDZNY) to CHF 53 from CHF...

5M ago

Sandoz Group Reports Strong H1 2025 Financial Results

Sandoz Group Ltd Sponsored ADR ( ($SDZNY) ) has released its Q2 earnings. Here is a breakdown of...

5M ago

SDZNY

Sandoz Group Ltd’s Strategic Growth Amid Market Challenges

Sandoz Group Ltd Sponsored ADR (($SDZNY)) has held its Q2 earnings call. Read on for the main highlights...

5M ago

SDZNY

Sandoz Group Reports Strong Growth and Strategic Advancements

Sandoz Group Ltd Sponsored ADR ( ($SDZNY) ) has released its Q4 earnings. Here is a breakdown of...

10M ago

SDZNY

Sandoz Group Ltd: Strong Financial Performance and Resilient Outlook Justify Buy Rating

In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on Sandoz Group...

10M ago

SDZNY FAQ

What was Sandoz Group Ltd Sponsored ADR’s price range in the past 12 months?

Sandoz Group Ltd Sponsored ADR lowest stock price was $36.26 and its highest was $74.38 in the past 12 months.

What is Sandoz Group Ltd Sponsored ADR’s market cap?

Sandoz Group Ltd Sponsored ADR’s market cap is $32.72B.

When is Sandoz Group Ltd Sponsored ADR’s upcoming earnings report date?

Sandoz Group Ltd Sponsored ADR’s upcoming earnings report date is Mar 18, 2026 which is in 79 days.

How were Sandoz Group Ltd Sponsored ADR’s earnings last quarter?

Sandoz Group Ltd Sponsored ADR released its earnings results on Aug 07, 2025. The company reported $0.882 earnings per share for the quarter, beating the consensus estimate of N/A by $0.882.

Is Sandoz Group Ltd Sponsored ADR overvalued?

According to Wall Street analysts Sandoz Group Ltd Sponsored ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sandoz Group Ltd Sponsored ADR pay dividends?

Sandoz Group Ltd Sponsored ADR pays a Annually dividend of $0.727 which represents an annual dividend yield of 0.98%. See more information on Sandoz Group Ltd Sponsored ADR dividends here

What is Sandoz Group Ltd Sponsored ADR’s EPS estimate?

Sandoz Group Ltd Sponsored ADR’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sandoz Group Ltd Sponsored ADR have?

Sandoz Group Ltd Sponsored ADR has 440,000,000 shares outstanding.

What happened to Sandoz Group Ltd Sponsored ADR’s price movement after its last earnings report?

Sandoz Group Ltd Sponsored ADR reported an EPS of $0.882 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.603%.

Which hedge fund is a major shareholder of Sandoz Group Ltd Sponsored ADR?

Currently, no hedge funds are holding shares in SDZNY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Sandoz Group Ltd Sponsored ADR Stock Smart Score

Neutral

Fundamentals

Return on Equity

2.68%

Trailing 12-Months

Asset Growth

11.86%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Sandoz Group Ltd Sponsored ADR

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

Sandoz Group Ltd Sponsored ADR (SDZNY) Earnings & Revenues

Historic Earnings Reports

SDZNY Company Deck

SDZNY Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted a strong first half performance driven by strategic launches and financial improvements. However, there are challenges related to price erosion and costs associated with separation. The sentiment is balanced with growth opportunities and market challenges.View all SDZNY earnings summaries